1. Home
  2. BDSX vs BHM Comparison

BDSX vs BHM Comparison

Compare BDSX & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • BHM
  • Stock Information
  • Founded
  • BDSX 2005
  • BHM 2022
  • Country
  • BDSX United States
  • BHM United States
  • Employees
  • BDSX N/A
  • BHM N/A
  • Industry
  • BDSX Precision Instruments
  • BHM Real Estate Investment Trusts
  • Sector
  • BDSX Health Care
  • BHM Real Estate
  • Exchange
  • BDSX Nasdaq
  • BHM Nasdaq
  • Market Cap
  • BDSX 53.2M
  • BHM 58.8M
  • IPO Year
  • BDSX 2020
  • BHM N/A
  • Fundamental
  • Price
  • BDSX $0.41
  • BHM $13.06
  • Analyst Decision
  • BDSX Strong Buy
  • BHM Strong Buy
  • Analyst Count
  • BDSX 5
  • BHM 1
  • Target Price
  • BDSX $1.75
  • BHM $15.00
  • AVG Volume (30 Days)
  • BDSX 1.4M
  • BHM 1.3K
  • Earning Date
  • BDSX 08-07-2025
  • BHM 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • BHM 3.92%
  • EPS Growth
  • BDSX N/A
  • BHM N/A
  • EPS
  • BDSX N/A
  • BHM N/A
  • Revenue
  • BDSX $76,556,000.00
  • BHM $71,496,000.00
  • Revenue This Year
  • BDSX $17.29
  • BHM N/A
  • Revenue Next Year
  • BDSX $29.33
  • BHM N/A
  • P/E Ratio
  • BDSX N/A
  • BHM N/A
  • Revenue Growth
  • BDSX 25.70
  • BHM 27.87
  • 52 Week Low
  • BDSX $0.17
  • BHM $9.30
  • 52 Week High
  • BDSX $2.04
  • BHM $17.40
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 53.27
  • BHM 45.61
  • Support Level
  • BDSX $0.37
  • BHM $12.75
  • Resistance Level
  • BDSX $0.43
  • BHM $13.98
  • Average True Range (ATR)
  • BDSX 0.04
  • BHM 0.16
  • MACD
  • BDSX -0.00
  • BHM -0.14
  • Stochastic Oscillator
  • BDSX 48.25
  • BHM 21.63

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The Company is an externally managed REIT managed and advised by Bluerock Homes Manager, LLC.

Share on Social Networks: